table of contents
Personalized Medicine in the Aftermath of COVID-19
Quick takes: Q&A with Jeff Evelhoch on Imaging Biomarkers for Alzheimer’s Disease
Something to Smile About: The Journey Toward a Cure with Rare Disease Foundation NFED
How Harvard Business School is Accelerating Precision Medicine
Quick takes: Q&A with Steve Anderson on bringing biomarkers from development to market
The Data-Powered Patient: Precision Medicine Enabled by Decentralized Identity and Blockchain
NC Creates Foundational Precision Health Initiative, Sara Imhof, Senior Director, Precision Health
North Carolina: a Global Life Science Leader, Sara Imhof, Senior Director, Precision Health
Best Practices for NGS-Based Cancer Diagnostics
Personalization and standardization: Can we have it all? What other industries can teach healthcare
Activating Patients: The Path to Personalizing Cancer Treatment
The Licensing Conundrum: How Licensing Can Facilitate (or Impede) Access to Research Models
Majors, Organizational Legitimacy and Rents from Blockbuster Innovation in the Biopharma Industry
Tweets
Only 72 hours left to register to hear how Texas Oncology is keeping up with Precision Medicine advances… https://t.co/WuuWhs2XJy, - New post: Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases https://t.co/oCMkrh10dL,
- New post: Sema4 Introduces “Sema4 Signal™”, a New Family of Products and Services Delivering Data-driven Precision O https://t.co/IbcX78peOv,